Research and Clinical Trials

Title  
BI1199.288: PerCEPt study - Molecular and Clinical Characteristics of Patients with Pulmonary Adenocarcinoma Tumours Associated with Early Progression on First-Line Platinum-doublet Chemotherapy study
Brief Description  
To evaluate the individual and collective associations between biological (biomarkers) and clinical characteristics of the lung adenocarcinoma tumour at the time of diagnosis and disease progression on first-line platinum-doublet chemotherapy.
Who may be Eligible  
Please contact us for eligibility criteria.
Speciality/Disorder  
Lung
Status  
OPEN
Start Date  
04/19/2017
IRB Number  
00021287
Principal Investigator  
Kim, Edward Sanghyun
Contact Name  
Jennifer L Ersek

For More Information, Contact  Jennifer  L, Ersek
Phone:  704-579-7940 Fax:    
Email:  Jennifer.Ersek@carolinashealthcare.org
Address: Suite 2200 Columbia, NC
Close